Ioannis K. Karalis
University of Crete
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ioannis K. Karalis.
European Journal of General Practice | 2009
Tomas Faresjö; Ioannis K. Karalis; Erik Prinsback; Katarina Kroon; Christos Lionis
Background/objective: The concept of ‘‘sense of coherence’’ (SOC) was introduced in 1987 by Aaron Antonovsky to describe a dispositional orientation, ‘‘a way of seeing the world’’, which is presumed to enhance health. This study reports on the results of the first implementation of SOC in rural Crete and discusses the findings, with a view to the potential impact on primary care delivery in rural Crete. Methods: This study forms part of a follow-up project initially established in 1988 in the rural area of Spili, Crete. All participants of the initial study still living in the area (n = 248) were eligible. Data were obtained from 200 subjects (91 males and 109 females) aged 28-92 years, resulting in a second-phase participation rate of 80.7%. The SOC scales (both the SOC-29 and SOC-13 forms) were recorded for 175 (87.1%) of the participants. Results: Comparing the SOC scores among Cretan males and females, there is a statistically significant difference (p < 0.0001), with men reporting a higher sense of coherence than women, regardless of the form of the questionnaire used. Cretan women seem to score significantly lower than their Swedish counterparts (p < 0.0001), while Cretan men tend to report a higher SOC compared to their matched Swedish reference population (p = 0.07). Discussion: The study introduces other issues worthy of additional research, particularly with regard to the significantly lower SOC scores obtained by Cretan women, compared to Cretan men. These low SOC scores raise the issue of a potential increase of psychiatric morbidity in the area, leading to a high impact on primary care services. Future investigation into the health impact of SOC factors could be of value to primary care physicians located in rural Crete.
Cardiovascular Drugs and Therapy | 2007
Stavros I. Chrysostomakis; Ioannis K. Karalis; Emmanuel N. Simantirakis; Anastasios V. Koutsopoulos; Hercules E. Mavrakis; Gregory Chlouverakis; Panos E. Vardas
BackgroundUsing a goat animal model, we tested the hypothesis that angiotensin-II inhibition reduces fibrotic degeneration of both the atrial and ventricular myocardium as well as AF induction susceptibility.MethodsWe studied three groups of five goats over a 6-month period. The study animals in the first two groups were implanted with a pacemaker capable of maintaining AF with burst pacing. Additionally, in one group, goats were administered candesartan (AF+candesartan group). The third group (SR group) of animals served as control. Animals were tested for AF induction on day 0, 1, 30, 90 and 180. A “Vulnerability Index” (VI) for AF induction was calculated, defined as the ratio of total time in AF per number of bursts needed to induce sustained AF, in each session. At the end of the study, all four heart chambers were examined and fibrosis quantified.ResultsBoth AF goat groups developed cardiomegaly due to tachy-cardiomyopathy. Although, the VI was significantly increased in AF group over time (28.8 ± 43 to 284.7 ± 291, p = 0.045), this was not the case for AF+candesartan group (30.3 ± 40 to 170.8 ± 243, p = 0.23). Histology revealed a significant increase of fibrous tissue in goats with induced AF, noticeable in all four heart chambers, compared to controls. However, the degree of fibrosis was significantly lower in AF animals on candesartan.ConclusionsOur study demonstrated a beneficial effect of angiotensin II inhibition on tachyarrhythmia-induced ventricular fibrosis. It is also consistent with previous studies indicating a reduction in burst-induced AF susceptibility in goats and confirms the favorable effects in atrial structural remodeling.
European Journal of Preventive Cardiology | 2009
Athanasios Pipilis; Georgios K. Andrikopoulos; John Lekakis; Kallirroi Kalantzi; Anastasia N. Kitsiou; Konstantina Toli; Dimitrios Floras; Dan Gaita; Ioannis K. Karalis; Spyridon Dragomanovits; Petros Kalogeropoulos; Andreas Synetos; Nikolaos Koutsogiannis; Pavlos Stougiannos; Chariton Antonakoudis; John A. Goudevenos
Aims To compare the treatment and outcomes of myocardial infarction patients in hospitals with and without catheterization laboratory. Methods and results The Hellenic Infarction Observation Study was a countrywide registry of acute myocardial infarction, conducted during 2005-2006. The registry enrolled 1840 patients with myocardial infarction from 31 hospitals with a proportional representation of all types of hospitals and of all geographical areas. Out of these patients, 645 (35%) were admitted in 11 hospitals with and 1195 (65%) in 20 hospitals without catheterization laboratory. Patients admitted in hospitals with catheterization laboratory in comparison with patients admitted in hospitals without were younger (66 ± 14 vs. 68 ±13, P < 0.004) with less diabetes (27 vs. 33%, P < 0.001), but without other baseline differences (female 27 vs. 25%, prior myocardial infarction 20 vs. 17%, Killip class >1 22 vs. 23%). Reperfusion rates for ST-segment elevation myocardial infarction were 67% (43% lytic, 24% primary percutaneous coronary interventions) versus 56% (55% lytic, 1% percutaneous coronary interventions; P < 0.01). In-hospital outcomes in hospitals with versus in hospitals without laboratory were: mortality 6.5 versus 8.3% (NS), stroke 2.2 versus 1.1% (NS), major bleeding 1.1 versus 0.6% (NS), and heart failure 11 versus 16% (P < 0.01). In multivariate regression analysis, being admitted in a hospital without catheterization laboratory was not an independent predictor of increased in-hospital mortality (odds ratio = 1.18, 95% confidence interval: 0.72-1.93, P = 0.505). Conclusion Although the majority of acute myocardial infarction patients was admitted in hospitals without catheterization laboratory, these patients do not have a survival disadvantage, provided they are treated with lytic therapy, medical secondary prevention drugs, and eventual revascularization according to current guidelines. Eur J Cardiovasc Prev Rehabil 16:85-90
BMC Public Health | 2007
Ioannis K. Karalis; Athanasios Alegakis; A. Kafatos; Antonios Koutis; Panos E. Vardas; Christos Lionis
BackgroundCrete has been of great epidemiological interest ever since the publication of the Seven Countries Study. In 1988 a well-defined area of rural Crete was studied, with only scarce signs of coronary heart disease (CHD) despite the unfavorable risk profile. The same population was re-examined twelve years later aiming to describe the trends of CHD risk factors over time and discuss some key points on the natural course of coronary heart disease in a rural population of Crete.Methods and ResultsWe re-examined 200 subjects (80.7% of those still living in the area, 62.4 ± 17.0 years old). The prevalence of risk factors for CHD was high with 65.9% of men and 65.1% of women being hypertensive, 14.3% of men and 16.5% of women being diabetic, 44% of men being active smokers and more than 40% of both sexes having hyperlipidaemia. Accordingly, 77.5% of the population had a calculated Framingham Risk Score (FRS) ≥ 15%, significantly higher compared to baseline (p < 0.001). The overall occurrence rate for CHD events was calculated at 7.1 per 1000 person-years (95% confidence interval: 6.8–7.3).ConclusionThe study confirms the unfavorable risk factor profile of a well defined rural population in Crete. Its actual effect on the observed incidence of coronary events in Cretans remains yet to be defined.
Journal of the American College of Cardiology | 2008
Emmanuel I. Skalidis; Michalis Hamilos; Ioannis K. Karalis; Gregory Chlouverakis; George E. Kochiadakis; Panos E. Vardas
Cardiovascular Pathology | 2007
Joanna E. Kontaraki; Fragiskos I. Parthenakis; Alexandros P. Patrianakos; Ioannis K. Karalis; Panos E. Vardas
International Journal of Cardiology | 2007
Frangiskos I. Parthenakis; Alexandros P. Patrianakos; Emmanuel I. Skalidis; George F. Diakakis; Evangelos A. Zacharis; Gregory Chlouverakis; Ioannis K. Karalis; Panos E. Vardas
Hellenic journal of cardiology | 2006
Stavros I. Chrysostomakis; Emmanuel N. Simantirakis; Sophia E. Schiza; Ioannis K. Karalis; N.C. Klapsinos; Nikolaos M. Siafakas; Panos E. Vardas
Hellenic journal of cardiology | 2007
Michalis Hamilos; George E. Kochiadakis; Ioannis K. Karalis; Emmanuel I. Skalidis; Nikolaos E. Igoumenidis; Panos E. Vardas
Hellenic journal of cardiology | 2010
Ioannis K. Karalis; George E. Kochiadakis; Nikos E. Igoumenidis; Emmanuel I. Skalidis; Stavros I. Chrysostomakis; Panos E. Vardas